Home›Research›Compare›5-Amino-1MQ vs Cagrilintide
Peptide Comparison
5-Amino-1MQ vs Cagrilintide
Both are Fat Loss peptides.
5-Amino-1MQ
5-Amino-1-methylquinolinium
40 providers listed
Cagrilintide
AM833
Half-life: ~7 days
13 providers listed
Quick Verdict
5-Amino-1MQ
Risk
Half-life
—
Cagrilintide
Risk
Half-life
~7 days
Side-by-Side Comparison
About 5-Amino-1MQ
Inhibits NNMT enzyme, increasing SAM (S-adenosylmethionine) availability. Alters adipocyte gene expression to reduce fat cell size and may increase brown adipose tissue activity via epigenetic mechanisms.
A small-molecule NNMT (nicotinamide N-methyltransferase) inhibitor that reduces adipocyte differentiation and promotes metabolic shifts in fat cells. Not a true peptide — a synthetic quinolinium compound frequently sold alongside peptide protocols by online vendors.
Research Areas
About Cagrilintide
Long-acting amylin analogue; acts on amylin/calcitonin receptors to prolong satiety; synergistic with semaglutide in CagriSema combination
A once-weekly long-acting amylin analogue in late-stage development. Showing impressive weight loss (~15%) in trials, especially when combined with semaglutide (CagriSema).
Research Areas
Find Providers
Where to source these peptides
Providers offering
5-Amino-1MQ
40 listed
Browse directory →
Providers offering
Cagrilintide
13 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More fat loss Comparisons
Browse all peptides →Educational research tools — not medical advice.